Discover the Copay Assistance Program

Eligible commercially insured patients may qualify for the Doptelet Copay Assistance Program

What's the program?

Eligible patients may pay as little as $0 for each Doptelet prescription
Annual maximum benefit up to $15,000

Eligible patients must:

Have commercial insurance that covers Doptelet
Not be enrolled in any state or covered by a state or federal healthcare program such as Medicare, Medicaid, Medigap, Veterans Affairs (VA), Department of Defense (DOD), or TRICARE
Be 18 years of age or older
Be a resident in the United States or a US Territory
Be prescribed Doptelet for an FDA-approved use

How to enroll:

Approved pharmacies, healthcare professionals, and Doptelet Connect can enroll patients
Patients can enroll themselves as well as their caregivers
Please call 1-833-368-2663 Monday–Friday 8 am–8 pm ET for more information

Terms and Conditions

Patients pay as little as $0 per prescription. Copay Assistance Program has an annual calendar cap of $15,000
Patient has an on-label prescription
The Copay Assistance Program is void where prohibited by law, taxes, or restricted
This offer is non-transferable, no substitutions are permissible, and this offer cannot be combined with any other rebate/coupon, free trial, or similar offer for the specified prescription
Sobi, Inc. reserves the right to rescind, revoke, or amend this offer at any time without notice
The Copay Assistance Program for Doptelet is not insurance and is not intended to substitute for insurance
Patients, pharmacists, and healthcare providers must not seek reimbursement from health insurance or any third party for any part of the benefit received by the patient through this Copay Assistance Program. Patients must not seek reimbursement from any health savings, flexible spending, or other healthcare reimbursement accounts for the amount of assistance received from the Copay Assistance Program
Certain information pertaining to your use of the Copay Assistance Program will be shared with Sobi, Inc., the sponsor of the Copay Assistance Program. The information disclosed will include the date the prescription is filled, the number of pills or product dispensed by the pharmacists, and the amount of your copay that will be paid for by using this Copay Assistance Program. For more information, please see the Sobi Privacy Policy at https://sobi-northamerica.com/privacy-policy
Acceptance in this Copay Assistance Program is not conditioned on any past, present, or future purchase, including additional doses
Enrollment for the Copay Assistance Program is valid through the calendar year
Sobi reserves the right to change Copay Assistance Program terms at any time

For Colorado Prescribers

Information for Colorado Prescribers of Prescription Drugs Provided Pursuant to Colorado House Bill 19-1131

SHARING WITH COLORADO PRESCRIBERS

PRICING AND GENERIC EQUIVALENT INFORMATION

IN CONNECTION WITH PRESCRIPTION DRUG MARKETING

Pursuant to Colorado House Bill 19-1131 (and codified in Colorado Revised Statutes 12-42.5-308 and 12-280-308), the following information is being shared with Colorado prescribers (as defined by Colorado HB 19-1131) in connection with prescription drug marketing activities.

Prescription Drug Name: Doptelet^® (avatrombopag)

Manufacturer Name: AkaRx, Inc., a wholly-owned subsidiary of Sobi, Inc.

Wholesale Acquisition Cost (WAC) of Doptelet^® (avatrombopag): $392.01 (tablet)*

Generic Prescription Drugs from the same therapeutic class (as defined by HB 19-1131): None

IMPORTANT NOTES:

WAC based on current price as of January 1, 2023
The WAC listed does not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness
Please refer to the product’s FDA-approved label and indication for further information